European Innovation Council

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

David Malo Jean

Director

Past deals in Simulation

PASQAL

Grant in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

PASQAL

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

FEops

Convertible Note in 2022
FEops is a pioneering company specializing in physics-based simulations for minimally invasive cardiovascular devices and procedures. It develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By providing artificial intelligence-enabled anatomical analyses, FEops generates data-driven insights that facilitate improvements in transcatheter valve procedures. The company collaborates with medical device developers and healthcare professionals, offering valuable simulations that accelerate research and development processes while ensuring device safety. Physicians benefit from these patient-specific insights, which enhance their efficiency and ultimately lead to improved clinical outcomes and patient safety.

AMSIMCEL

Seed Round in 2022
AMSIMCEL is a deep tech company based in Bucharest, founded in 2017, that specializes in developing advanced computing software for the semiconductor industry. The firm focuses on creating a Physical Verification framework powered by GPU technology, which enhances the efficiency of integrated circuits (IC) verification processes. By integrating advanced parallel computing and automating circuit verification, AMSIMCEL aims to accelerate machine simulations and improve design methodologies for complex projects. The company's innovations are intended to support clients in expediting their IC design and verification processes while ensuring the delivery of custom intellectual property and high-quality, bug-free silicon.

AMSIMCEL

Grant in 2022
AMSIMCEL is a deep tech company based in Bucharest, founded in 2017, that specializes in developing advanced computing software for the semiconductor industry. The firm focuses on creating a Physical Verification framework powered by GPU technology, which enhances the efficiency of integrated circuits (IC) verification processes. By integrating advanced parallel computing and automating circuit verification, AMSIMCEL aims to accelerate machine simulations and improve design methodologies for complex projects. The company's innovations are intended to support clients in expediting their IC design and verification processes while ensuring the delivery of custom intellectual property and high-quality, bug-free silicon.

PASQAL

Grant in 2022
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

SAALG Geomechanics

Venture Round in 2022
Founded in 2016, SAALG Geomechanics specializes in real-time ground analysis software for civil works and building projects. It offers machine learning-driven solutions to anticipate ground movement issues, along with numerical models calibrations, soil parameter characterization, and geotechnical consulting services.

SAALG Geomechanics

Grant in 2022
Founded in 2016, SAALG Geomechanics specializes in real-time ground analysis software for civil works and building projects. It offers machine learning-driven solutions to anticipate ground movement issues, along with numerical models calibrations, soil parameter characterization, and geotechnical consulting services.

PASQAL

Series A in 2021
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

FEops

Grant in 2019
FEops is a pioneering company specializing in physics-based simulations for minimally invasive cardiovascular devices and procedures. It develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By providing artificial intelligence-enabled anatomical analyses, FEops generates data-driven insights that facilitate improvements in transcatheter valve procedures. The company collaborates with medical device developers and healthcare professionals, offering valuable simulations that accelerate research and development processes while ensuring device safety. Physicians benefit from these patient-specific insights, which enhance their efficiency and ultimately lead to improved clinical outcomes and patient safety.

KINE Robot Solutions

Grant in 2018
KINE Robot Solutions specializes in the design and development of robotic systems tailored for industrial applications globally. The company creates customized solutions that streamline various industrial processes, utilizing advanced three-dimensional simulations that incorporate components such as grippers, conveyors, tools, machines, and sensor systems. These systems can be seamlessly integrated into existing environments and are operated via a user-friendly touchscreen interface. In addition to system design, KINE also offers maintenance services and training programs to ensure effective use of the robots, providing clients with cost-effective alternatives for enhancing production efficiency and ensuring timely upkeep.

FEops

Series B in 2017
FEops is a pioneering company specializing in physics-based simulations for minimally invasive cardiovascular devices and procedures. It develops advanced cardiac imaging technology that enhances personalized treatment for patients with structural heart disease. By providing artificial intelligence-enabled anatomical analyses, FEops generates data-driven insights that facilitate improvements in transcatheter valve procedures. The company collaborates with medical device developers and healthcare professionals, offering valuable simulations that accelerate research and development processes while ensuring device safety. Physicians benefit from these patient-specific insights, which enhance their efficiency and ultimately lead to improved clinical outcomes and patient safety.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.